期刊文献+

基于加权TOPSIS法评价与药学干预对癌痛治疗效果的分析

Effect of evaluation based on weighted TOPSIS method and pharmaceutical intervention on the treatment of cancer pain
收藏 分享 导出
摘要 目的促进癌痛治疗的合理性。方法多学科讨论制订癌痛治疗合理性评价细则,并据此采用加权TOPSIS法对本院2017年7-12月的60份癌痛病历进行评价。根据评价结果进行药学干预,干预后采用相同的评价方法评价2018年1-6月份60份癌痛病历,对比干预前后癌痛治疗合理性变化。结果 2017年7-12月60份病历中相对接近度最高的为85.19%,最低的为48.60%,大于60%的有44例(占73.33%);2018年1-6月60份病历中相对接近度最高的为95.32%,最低的为49.40%,大于60%的有55例(占91.67%)。药学干预前后癌痛治疗合理性差异有统计学意义(P<0.05)。结论基于加权TOPSIS法制订的癌痛治疗合理性评价方法把影响癌痛治疗的多个因素结合起来,相对传统单个指标评价,评价结果更加简明扼要、直观、可靠。药学干预可以提高癌痛治疗的合理性。 Objective To promote rational treatment for cancer pain. Methods We formulated rules for rational evaluation of cancer pain by multidisciplinary discussion, and the weighted TOPSIS method was used to evaluate 60 cases of cancer pain in our hospital from July to December of 2017. We had pharmaceutical intervention according to the evaluation results, the same method was used to evaluate another 60 cases of cancer pain from January to June of 2018 after the pharmaceutical intervention. We compared the rationality of cancer pain treatment before and after the pharmaceutical intervention. Results Among the 60 cases from July to December of 2017, there were 44(73.3%) showed proximity degree higher than 60%, the highest degree at 85.19%, and the lowest degree at 48.60%. Among the 60 cases from January to June of 2018, 55(95.32%) degree higher than 60%, the highest degree at 95.32%, and the lowest degree at 49.40%. The rationality of cancer pain treatment was significant after the pharmaceutical intervention(P<0.05). Conclusion The rationality evaluation of cancer pain based on the weighted TOPSIS method combines multiple factors that affect the treatment of cancer pain. The evaluation is more concise, intuitive and reliable than the traditional single index evaluation. Pharmaceutical intervention can improve the rationality of cancer pain treatment.
作者 宋佳伟 李春贤 施朕善 徐珊珊 陈慧娟 曾诚 SONG Jia-wei;LI Chun-xian;SHI Zhen-shan;XU Shan-shan;CHEN Hui-juan;ZENG Cheng(Department of Pharmacy,People's Hospital of Bozhou,Bozhou Anhui 236800;Department of Nursing,People's Hospital of Bozhou,Bozhou Anhui 236800;Department of Oncology,People's Hospital of Bozhou,Bozhou Anhui 236800)
出处 《中南药学》 CAS 2019年第2期281-285,共5页 Central South Pharmacy
关键词 加权TOPSIS法 癌痛规范化治疗 药学干预 合理性评价 weighted TOPSIS method treatment for cancer pain pharmaceutical intervention rationality evaluation
作者简介 宋佳伟,男,硕士,主管药师,主要从事临床药学、肿瘤药学研究,Tel:(0558)5675187,E-mail:403824516@qq.com;通讯作者:曾诚,男,博士,副主任药师,主要从事临床药学、药理学,Tel:(0558)5675187,E-mail:1049335879@qq.com.
  • 相关文献

参考文献12

二级参考文献51

  • 1张晓琳,焦明丽,王国栋,黄照权,吴群红,张靖婧,张弛,刘鹤,赵思奇.基于TOPSIS法的某省新医疗改革中政府相关责任的分析[J].中国卫生经济,2015,0(6):22-24. 被引量:7
  • 2刘继斌,曲成毅,王瑞花.基于属性AHM的Topsis综合评价及其应用[J].现代预防医学,2006,33(10):1862-1863. 被引量:23
  • 3陈新谦 金有豫 汤光.新编药物学[M]15版[M].北京:人民卫生出版社,2003.583. 被引量:457
  • 4王晖,陈丽,陈垦,薛漫清,梁庆.多指标综合评价方法及权重系数的选择[J].广东药学院学报,2007,23(5):583-589. 被引量:204
  • 5Breivik H,Cherny N,Collett F,et al.Cancer-related pain:a pan European survey of prevalence,treatment,and patient attitudes.Ann Oncol,2009,20:1420-1433. 被引量:1
  • 6Frankish H.15 million new cancer cases per year by2020,says WHO.Lancet,2003,361:1278. 被引量:1
  • 7Van den Beuken-van Everdingen MH,de Rijke JM,Kessels AG,et al.Prevalence of pain in patients with cancer:a systematic review of the past 40 years.Ann Oncol,2007,18:1437-1449. 被引量:1
  • 8Deandrea S,Montanari M,Moja L,et al.Prevalence of undertreatment in cancer pain.A review of published literature.Ann Oncol,2008,19:1985-1991. 被引量:1
  • 9Costantini M,Ripamonti C,Beccaro M,et al.Prevalence,distress,management and relief of pain during the last three months of cancer patients’life.Results of an Italian mortality follow-back survey.Ann Oncol,2009,20:729-735. 被引量:1
  • 10Wang XS,Mendoza TR,Gao SZ,et al.The Chinese version of the Brief Pain Inventory(BPI-C):its development and use in a study of cancer pain.Pain.1996,67:407-416. 被引量:1

共引文献737

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈